Back
Takeda Pharmaceutical 10K Form
Sell
25
TAK
Takeda Pharmaceutical
Last Price:
13.54
Seasonality Move:
3.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TAK News And Ratings
See the #1 stock for the next 7 days that we like better than TAK
TAK Financial Statistics
Sales & Book Value
| Annual Sales: | $29.55B |
|---|---|
| Cash Flow: | $1.28B |
| Price / Cash Flow: | 12.64 |
| Annual Sales: | $15.29 |
| Price / Book: | 0.89 |
Profitability
| EPS (TTM): | 0.60440 |
|---|---|
| Net Income (TTM): | $1.93B |
| Gross Margin: | $19.66B |
| Return on Equity: | 4.01% |
| Return on Assets: | 1.91% |
Takeda Pharmaceutical Earnings Forecast
Key Takeda Pharmaceutical Financial Ratios
- The Gross Profit Margin over the past 25 years for TAK is 66.54%.
- The Selling, General & Administrative Expenses for TAK have been equal to 24.72% of Gross Profit Margin.
- The Research & Development expenses have been 17.12% of Revenue.
- The Interest Expense is 82.97% of Operating Income.
- The Net Earning history of TAK is 3.38% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 15 years.
Takeda Pharmaceutical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TAK |
| CUSIP: | 874060 |
| Website: | takeda.com |
Debt
| Debt-to-Equity Ratio: | 0.73 |
|---|---|
| Current Ratio: | 1.28 |
| Quick Ratio: | 0.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 43.21 |
|---|---|
| Forward P/E Ratio: | 0 |
TAK Technical Analysis vs Fundamental Analysis
Sell
25
Takeda Pharmaceutical (TAK)
is a Sell
Is Takeda Pharmaceutical a Buy or a Sell?
-
Takeda Pharmaceutical stock is rated a Sell
The current Takeda Pharmaceutical [TAK] share price is $13.65. The Score for TAK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.